JBIO
Jade Biosciences
JBIO
JBIO
64 hedge funds and large institutions have $524M invested in Jade Biosciences in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 22 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
64
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$7.61M | |
| 2 | +$6.82M | |
| 3 | +$2.3M | |
| 4 |
VA
VR Adviser
New York
|
+$1.74M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.6M |
Top Sellers
| 1 | -$45.8M | |
| 2 | -$7.98M | |
| 3 | -$6.36M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.14M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.13M |